Medicine, Cardiology Division

Grants

Grants per year 1999 2014 2015 2016 2017 2018 2019 2020 2021 2022 2031

• 238 Active
• 600 Finished

Grants per year

Search results

• Research project

  Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF

  Ahmad, F. S.

  Duke University, National Heart, Lung, and Blood Institute

  12/10/19 → 7/31/22

  Project: Research project

• Data Portal Core - Subproject for Institution # SP0066427

  Kho, A. N., Wehbe, F., Ahmad, F. S. & Jacobs, M.

  National Heart, Lung, and Blood Institute

  9/13/21 → 6/30/26

  Project: Research project

• Mapping Modifiers of Cardiomyopathy in Muscular Dystrophy

  McNally, E. M.

  University of Florida, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/18 → 7/31/19

  Project: Research project

  • Muscular Dystrophy 100%
  • mice 57%
  • Mouse Model 57%
  • Serositis 28%
  • Sarcolemma 28%

• Institutional NRSA in Support of Research Training in CVD Epidemiology and Prevention

  Greenland, P., Bonow, R. O., Dunaif, A. E., Dyer, A. R., Gheorghiade, M., Liu, K., McDermott, M. M., Stamler, J. & Van Horn, L.

  National Heart, Lung, and Blood Institute

  7/1/03 → 9/14/08

  Project: Research project

• New Directions in Biology and Disease of Skeletal Muscle

  McNally, E. M.

  National Institute of Neurological Disorders and Stroke

  4/1/18 → 3/31/19

  Project: Research project

  • diseases 100%
  • Neuromuscular Disease 71%
  • muscles 42%
  • biology 42%
  • atrophy 28%

• Cardiac lymphatic endothelial cells: novel players in cardiomyocyte survival during heart development and repair

  Liu, X., Ardehali, H., Burridge, P., McNally, E. M., Quaggin, S. E. & Thorp, E. B.

  American Heart Association

  7/1/18 → 6/30/21

  Project: Research project

  • Lymph Duct 100%
  • Survival 66%
  • Development 44%
  • mice 44%
  • Heart Injury 33%

• Prot #GS-US-361-1157: A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS 6615 on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy

  Shah, S. J.

  PPD Development, Gilead Sciences, Inc.

  7/25/14 → 7/25/20

  Project: Research project

• Prot#ABT-CIP-10249: TRILUMINATE Pivotal: Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal

  Davidson, C. J., Ricciardi, M. J. & Puthumana, J. J.

  Abbott Cardiovascular Systems, Inc.

  6/10/20 → 6/9/24

  Project: Research project

• Prot # 1501:REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure.

  Shah, S. J.

  Corvia Medical, Inc.

  1/21/16 → 1/21/24

  Project: Research project

• Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovascular and Kidney Diseases

  Carnethon, M. R., Wolf, M. S., Carnethon, M. R., Kershaw, K. N., Ardehali, H., Cornelis, M. C., David, N. V., Isakova, T., Zhao, L. & Yancy, C. W.

  American Heart Association

  7/1/15 → 6/30/20

  Project: Research project

  • Cardiovascular Disease 100%
  • Disparity 50%
  • Mediator 50%
  • Phosphate 50%
  • Fibroblast Growth Factor 23 50%

• Prot# 1160.26: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate with Open-Label Warfarin for the Prevention of Stroke and Systemic Embolism inPatients

  Arora, R. K., Bernstein, R. A., Denes, P., Mehlman, D. J. & Passman, R. S.

  Boehringer Ingelheim International GmbH

  9/15/06 → 12/1/11

  Project: Research project

• Great Lakes Practice Transformation Network

  Kho, A. N., Jean-Jacques, M., McGee, M. F., Mutharasan, R. K., Ramsey-Goldman, R., French, D. D., Persell, S. D., Walunas, T. L. & Woods, D.

  Indiana University-Purdue University Indianapolis, Centers for Medicare & Medicaid Services

  9/29/15 → 12/28/19

  Project: Research project

  • transformations 100%
  • Patient 80%
  • Total Quality Management 80%
  • great lakes 60%
  • Clinician 60%

• Understanding Outcomes with the EMBLEM™ S-ICD in Primary Prevention Patients with Low Ejection Fraction - UNTOUCHED

  Knight, B. P.

  Cameron Health, Inc.

  9/29/16 → 9/29/22

  Project: Research project

• Prot# ABSALOM: Atrial-Based Pacing Stimulation and Level of Mobility

  Passman, R. S. & Denes, P.

  Medtronic, Inc.

  2/3/04 → 8/7/09

  Project: Research project

• New Frontiers in Cardiovascular Research and Therapy

  McNally, E. M.

  National Heart, Lung, and Blood Institute

  7/20/21 → 6/30/22

  Project: Research project

  • Cardiovascular System 100%
  • conferences 54%
  • Networking 36%
  • Investigator 27%
  • Heart 18%

• Prot# ABT-CIP-10304: REPAIR-MR: Percutaneous or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation Whose Mitral Valve has been Determined to be Suitable for Correction by MV Repair Surgery

  Davidson, C. J., Malaisrie, S. C., McCarthy, P. M. & Mutharasan, R. K.

  Evalve, Inc.

  3/12/20 → 3/11/24

  Project: Research project

• E2F1 in Cardiac Neovascularization

  Qin, G. & Stock, S. R.

  National Heart, Lung, and Blood Institute

  4/9/10 → 2/28/15

  Project: Research project

• EXCEL Study - 10-389: Evaluation of XIENCE PRIME or XIENCE V versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization

  Davidson, C. J.

  Abbott Cardiovascular Systems, Inc.

  2/27/12 → 2/27/15

  Project: Research project

• Prot# ATI-2042-CLN-205: A Randomized, Double-Blind, Placebo-Controlled Study of ATI-2042 in Patients with Paroxysmal Atrial Fibrillation and Pacemakers with Atrial Fibrillation Data Logging Capabilities

  Passman, R. S., Arora, R. K. & Denes, P.

  ARYx Therapeutics

  11/8/07 → 11/8/10

  Project: Research project

• Risk-Based Primary Prevention of Heart Failure

  Khan, S. S., Lloyd-Jones, D. M., Luo, Y., Petito, L. C. & Welty, L. J.

  National Heart, Lung, and Blood Institute

  9/1/22 → 8/31/24

  Project: Research project

  • heart failure 100%
  • Heart Failure 89%
  • risks 57%
  • Heart Ejection Fraction 36%
  • Ejection Fraction 26%

• Prot#NU 14B07: A Prospective Study of Early Stage Breast Cancer Patients with Abnormal Myocardial Deformation treated with Anthracycline and/or Trastuzumab and Pertuzumab-based cancer therapy.

  Akhter, N.

  Abbott Laboratories

  12/17/19 → 1/7/23

  Project: Research project

• Adenosine Myocardial Perfusion Imaging in Patients with Peripheral Arterial Disease and No Clinically Evident Coronary Artery Disease: A Pilot Study to Determine the Prevalence of High Risk Stress Tests

  Holly, T. A., Bonow, R. O., Greenland, P. & Pearce, W. H.

  Fujisawa Healthcare, Inc.

  4/29/04 → 4/25/11

  Project: Research project

• Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction

  Ardehali, H., Burridge, P. & D'Aquila, R. T.

  National Heart, Lung, and Blood Institute

  1/1/18 → 12/31/22

  Project: Research project

  • Human Immunodeficiency Virus 100%
  • hiv 100%
  • Ejection Fraction 54%
  • Heart Failure 54%
  • Person 45%

• CAP2 - Continued Access to PREVAIL

  Knight, B. P.

  Boston Scientific Corporation

  8/6/13 → 8/6/22

  Project: Research project

• Role of anticoagulants contraindications, adherence, and drug cost-sharing on racial disparity in the prescription of novel oral anticoagulants and future risk of thromboembolic stroke

  Kho, A. N., Greenland, P. & Passman, R. S.

  Vanderbilt University Medical Center, Bristol-Myers Squibb Company

  11/1/20 → 2/28/22

  Project: Research project

  • Anticoagulation 100%
  • Atrial Fibrillation 50%
  • Racial Disparity 50%
  • Cost Sharing 33%
  • Antithrombotic 33%